Duke University Medical School, Durham, NC, USA.
Hematology Am Soc Hematol Educ Program. 2011;2011:532-7. doi: 10.1182/asheducation-2011.1.532.
Systemic iron balance must be tightly regulated to prevent the deleterious effects of iron deficiency and iron overload. Hepcidin, a circulating hormone that is synthesized by the liver, has emerged as a key regulator of systemic iron homeostasis. Hepcidin inhibits the absorption of dietary iron from the intestine and the release of iron derived from red blood cells from macrophages. Therefore, variation in hepcidin levels modifies the total amount of iron stored in the body and the availability of iron for erythropoiesis. The production of hepcidin by the liver is modulated by multiple physiological stimuli, including iron loading, inflammation, and erythropoietic activity. Investigation of the functions of the gene products mutated in inherited iron disorders using tissue-culture systems and animal models has provided valuable insights into the mechanisms by which these hepcidin responses are mediated. This review focuses on recent advances in our understanding of the molecular mechanisms underlying the regulation of systemic iron homeostasis.
机体的铁平衡必须得到严格的调控,以防止缺铁和铁过载带来的有害影响。铁调素(hepcidin)是一种由肝脏合成的循环激素,它已成为调控全身铁稳态的关键因子。铁调素可抑制肠道对膳食铁的吸收,以及巨噬细胞中来源于红细胞的铁释放。因此,铁调素水平的变化可调节体内储存的铁总量和铁用于红细胞生成的可利用度。肝脏中铁调素的产生受到多种生理刺激的调节,包括铁负荷、炎症和红细胞生成活性。利用组织培养系统和动物模型对遗传性铁代谢紊乱相关基因突变的基因产物的功能进行研究,为阐明这些铁调素反应的介导机制提供了有价值的见解。本综述重点介绍了我们在理解调控全身铁稳态的分子机制方面的最新进展。